*CANCELED* Rosenman D-Series: Aaron Sandoski, Norwich Ventures. "What Is Success in Healthtech Convergence?"

Unfortunately, due to COVID-19 concerns, Norwich Ventures has instated a company travel ban. Attendees with paid tickets will be refunded. Aaron is unable to travel to San Francisco for this talk. He expects to be able to make it in the fall, and we look forward to seeing you then.

Startup founders whose technologies embody the convergence of AI, data, or telehealth with traditional engineering must develop wide-ranging business models. It is no longer enough to focus on a product by itself; founders must take a systems approach and consider all stakeholders that interact with the data or technology. Aaron Sandoski, co-founder & managing director of Norwich Ventures, will explain how his investment firm assesses early-stage companies with convergent technologies.

Where & When

Room N-114, Genentech Hall, UCSF Mission Bay (600 16th St., San Francisco)
Tuesday, March 10, 2020, 5:30 to 6:30 PM

About the Speaker

sandoski 200.png

Aaron Sandoski is Co-Founder & Managing Director of Norwich Ventures, a specialized venture capital firm focused on early-stage MedTech.  Aaron’s current investments include Affera, Arterys, Lexington Medical, Pelvalon, Podimetrics, ReThink Medical and Vaxess Technologies.  Previous investments include Rhythmia Medical (acquired by Boston Scientific) and Intelligent Bio-systems (acquired by Qiagen).  Prior to founding Norwich Ventures, Aaron worked for DEKA R&D, the engineering think tank of Dean Kamen.  He has also worked in start-up operations where he helped launch a subsidiary of Express Scripts and helped launch a venture-backed payments company. Aaron began his career as a consultant at McKinsey & Company, where he advised healthcare clients ranging from leading medical device companies to a rural hospital system.  Aaron is co-author of How the Wise Decide (Crown Business), a book on best practices in making tough decisions, which has been translated into 11 foreign languages.  Aaron earned an MBA from Harvard Business School and graduated summa cum laude from Dartmouth College with a double A.B. in Chemistry and Economics.